This important book proposes revising the current informed consent prool for predictive genetic testing to reflect the trend toward patient-centered medicine. Emphasizing the predictive aspect of testing, the author analyzes the state of informed consent procedure in terms of three components: comprehension of risk assessment, disclosure to select appropriate treatment, and voluntariness. The book's revised model revisits these cornerstones, restructuring the consent process to allow for expanded comprehension time, enhanced patient safety, greater patient involvement and autonomy, and reduced chance of coercion by family or others. A comparison of the current and revised versions and case studies showing the new model in real-world applications add extra usefulness to this resource. • The science behind PGT. • Understanding genetic risks and probability. • The history of informed consent. • Revised model of informed consent: comprehension, disclosure, voluntariness, patient safety. • Applications of the model in DTC and pleiotropic genetic testing. • Implementation of the revised model, and assessing its effectiveness.